QMS Medical Allied Services Ltd

QMS Medical Allied Services Ltd

₹ 122 -1.25%
18 Jul - close price
About

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Key Points

Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.

  • Market Cap 219 Cr.
  • Current Price 122
  • High / Low 189 / 90.2
  • Stock P/E 24.3
  • Book Value 44.0
  • Dividend Yield 0.41 %
  • ROCE 14.7 %
  • ROE 12.1 %
  • Face Value 10.0

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
24.51 27.46 20.70 31.37 25.96 28.64 35.24 32.29
22.83 24.57 17.09 28.21 21.30 23.74 30.40 28.34
Operating Profit 1.68 2.89 3.61 3.16 4.66 4.90 4.84 3.95
OPM % 6.85% 10.52% 17.44% 10.07% 17.95% 17.11% 13.73% 12.23%
0.17 0.18 0.19 0.19 0.08 0.11 0.15 0.11
Interest 0.75 0.66 0.23 0.65 0.59 0.74 0.81 0.99
Depreciation 0.19 0.19 0.32 0.37 0.82 0.86 0.88 0.88
Profit before tax 0.91 2.22 3.25 2.33 3.33 3.41 3.30 2.19
Tax % 26.37% 26.13% 22.77% 33.05% 26.13% 25.22% 25.76% 29.68%
0.67 1.64 2.51 1.57 2.46 2.56 2.44 1.54
EPS in Rs 0.45 1.09 1.41 0.88 1.38 1.43 1.37 0.86
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 52 73 122 146 104 122
0 47 63 105 130 93 104
Operating Profit 0 5 10 17 17 11 18
OPM % 12% 9% 13% 14% 11% 11% 15%
0 0 0 0 1 1 0
Interest 0 0 1 1 2 2 3
Depreciation 0 0 0 1 1 1 3
Profit before tax 0 4 9 15 14 9 12
Tax % 0% 30% 28% 27% 26% 27% 26%
0 3 6 11 11 6 9
EPS in Rs 10.00 3,070.00 21.00 29.02 28.41 3.57 5.04
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 19%
3 Years: 0%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 24%
3 Years: -6%
TTM: 41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -13%
Return on Equity
10 Years: %
5 Years: 25%
3 Years: 17%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0 0 3 4 4 18 18
Reserves 0 3 6 17 27 53 61
0 5 12 20 32 26 35
5 10 12 20 19 22 22
Total Liabilities 5 18 33 60 82 118 135
0 0 3 10 8 25 26
CWIP 0 0 0 0 0 1 0
Investments 0 0 0 0 0 0 2
5 18 30 50 75 91 108
Total Assets 5 18 33 60 82 118 135

Cash Flows

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 0 7 2 -2 -8 1
0 -0 -4 -8 2 -25 -3
0 0 -3 7 0 32 0
Net Cash Flow 0 0 1 1 1 -1 -1

Ratios

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 411 56 56 69 105 137 124
Inventory Days 22,891 76 103 82 80 140 172
Days Payable 26,124 75 73 73 56 91 90
Cash Conversion Cycle -2,822 58 86 77 129 187 205
Working Capital Days 137 52 85 84 131 222 250
ROCE % 121% 65% 54% 30% 14% 15%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2022Mar 2023Sep 2023Mar 2024
73.67% 73.67% 73.67% 73.67%
0.71% 1.21% 1.02% 0.01%
25.62% 25.12% 25.32% 26.33%
No. of Shareholders 9251,0431,2131,586

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents